How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?

Documenti analoghi

• Outcomes and opportunities: evaluating an unselected cohort of patients with adrenal incidentaloma at a tertiary hospital in New Zealand
  di: Anthony Benfell, et al.
  Pubblicazione: (2026)
• Correction to “Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial”
  Pubblicazione: (2025)
• Responses to systemic and topical glucocorticoids in coeliac crisis
  di: Edward Meehan, et al.
  Pubblicazione: (2024)
• How should journals respond to the emerging challenges of artificial intelligence?
  di: Paul Komesaroff, et al.
  Pubblicazione: (2024)
• Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)
  di: Hans Furuland, et al.
  Pubblicazione: (2026)